Abstract:Background: Acute liver injury (ALI) is a severe liver disease. Chitinase 3-like-1 (CHI3L1), a protein belonging to the glycosyl hydrolase family 18, is involved in many diseases, such as inflammatory diseases, bacterial infections, and various malignant tumors; however, the function of CHI3L1 in ALI remains unclear. The objective of this study was to evaluate the protective functions of CHI3L1 against thioacetamide (TAA)induced ALI in mice and explore its potential mechanisms. Methods: Data from 20 patients with ALI and 10 healthy subjects was collected. Serum CHI3L1, serum aspartate transaminase (AST), and serum alanine aminotransferase (ALT) were measured. To establish ALI mouse models, thioacetamide was intraperitoneally injected into groups of the CHI3L1-knockout (CHI3L1KO) and wild-type (WT) mice (80 and 150 mg/kg). Recombinant CHI3L1 protein (rCHI3L1) (5 mu g/kg), IFN-gamma (500 ng), and WP1033 (an inhibitor of P-STAT3, 0.2 mL) were injected before TAA treatment, after which the effects were estimated. Splenic CD4+CD62L+ naive T cells were isolated from CHI3L1-KO mice and stimulated to differentiate into regulatory T (Treg) cells, T-helper 1 (Th1) cells, T-helper 2 (Th2) cells, and T-helper 17 (Th17) cells. Results: Increased serum CHI3L1 levels were seen both in healthy subjects and post-therapy patients compared with ALI patients. CHI3L1 levels were negatively correlated with serum ALT and AST levels in ALI patients. CHI3L1-KO group showed higher serum ALT and AST levels than the WT group following TAA treatment, while tail vein injection of rCHI3L1 reduced liver tissue injury and improved Treg cell differentiation in vivo. In vitro experiment showed that knockout of CHI3L1 improved IFN-gamma+ Th1 cell differentiation. Furthermore, intraperitoneal administration of IFN-gamma produced more severe hepatocellular necrosis compared with rCHI3L1 injection alone. Mechanism study showed that T-box expressed in T cells (T-bet), and signal transducer and activator of transcription 3 (STAT3), play a critical role in adversely mediating the effect of CHI3L1, which is consistent with the finding that treatment with WP1033 down regulated the differentiation of the Th1 cells in vitro and reduced severity of liver injury in vivo. Conclusions: CHI3L1 reduced the production of IFN-gamma and inhibited Th1 cell differentiation through the STAT3 signaling pathway, which could be a potential therapeutic strategy for treating ALI.

SIRT3 inhibitor 3-TYP exacerbates thioacetamide-induced hepatic injury in mice

The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.

Protective Role of AGK2 on Thioacetamide-Induced Acute Liver Failure in Mice

Role of SIRT1 in Hepatic Encephalopathy: in Vivo and in Vitro Studies Focusing on the NLRP3 Inflammasome.

SIRT6 Activator UBCS039 Inhibits Thioacetamide-Induced Hepatic Injury in Vitro and in Vivo

CHI3L1 Alleviate Acute Liver Injury by Inhibiting Th1 Cells Differentiation Through STAT3 Signaling Pathway.

Stim-3 Alleviates Liver Injury Via Regulation of the Immunity Microenvironment and Autophagy

Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation

Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy

SIRT3 deficiency exacerbates early-stage fibrosis after ischaemia-reperfusion-induced AKI

METTL3 Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Activating the MAPK Signaling Pathway

Hepatic Sirt6 activation abrogates acute liver failure

Cytochrome P450 Dysregulations in Thioacetamide-Induced Liver Cirrhosis in Rats and the Counteracting Effects of Hepatoprotective Agents

Triiodothyronine Attenuates Hepatic Ischemia/reperfusion Injury in a Partial Hepatectomy Model Through Inhibition of Proinflammatory Cytokines, Transcription Factors, and Adhesion Molecules

Sirtuin 5‐Mediated Desuccinylation of ALDH2 Alleviates Mitochondrial Oxidative Stress Following Acetaminophen‐Induced Acute Liver Injury

TIPE3 protects mice from lipopolysaccharide-induced acute lung injury

SIRT3: A potential therapeutic target for liver fibrosis

Toxic Effects of Chronic Low-Dose Exposure of Thioacetamide on Rats Based on NMR Metabolic Profiling

SIRT5 safeguards against T-2 toxin induced liver injury by repressing iron accumulation, oxidative stress, and the activation of NLRP3 inflammasome

AGK2 Pre-Treatment Protects Against Thioacetamide-Induced Acute Liver Failure Via Regulating the MFN2-PERK Axis and Ferroptosis Signaling Pathway.

Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice